Last quarter (Q3 2023), Predictive Oncology's total revenue was $715.06K, an increase of 56.87% from the same quarter last year. In Q3, Predictive Oncology's net income was $-3.16M. See Predictive Oncology’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 1.81M	$ 1.51M	-	$ 1.25M	$ 1.41M	$ 1.41M
Cost of Revenue	$ -6.88K	$ 505.11K	$ 487.02K	$ 447.19K	$ 531.81K	$ 415.76K
Gross Profit	$ 1.27M	$ 1.00M	$ -487.02K	$ 805.08K	$ 879.75K	$ 995.89K
Operating Expense	$ 2.95M	$ 3.80M	$ 14.41M	$ 13.29M	$ 14.65M	$ 8.86M
Operating Income	$ -8.04M	$ -26.03M	$ -14.89M	$ -12.48M	$ -13.77M	$ -7.86M
Net Non Operating Interest Income Expense	-	-	-	-	-	-
Other Income Expense	$ 2.63M	$ 3.05M	$ 1.36M	$ -13.40M	$ -5.62M	$ -2.23M
Pretax Income	$ -11.01M	$ -25.74M	$ -20.32M	$ -25.88M	$ -19.39M	$ -10.09M
Tax Provision	-	$ -856.74K	$ -661.66K	$ 0.00	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -11.01M	$ -25.74M	$ -19.66M	$ -26.44M	$ -19.68M	$ -10.09M
Basic EPS	$ -2.72	$ -0.35	-	$ -2.21	$ -6.86	$ -7.87
Diluted EPS	$ -2.47	$ -0.35	$ -7.20	$ -2.21	$ -6.86	$ -7.87
Basic Average Shares	$ 84.99M	$ 73.00M	$ 2.74M	$ 11.95M	$ 2.87M	$ 1.28M
Diluted Average Shares	$ 84.99M	$ 73.00M	$ 2.73M	$ 11.95M	$ 2.87M	$ 1.28M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 2.94M	$ 4.30M	$ 14.89M	$ 13.74M	$ 15.19M	$ 9.27M
Net Income From Continuing And Discontinued Operation	$ -18.42M	$ -25.74M	$ -19.66M	$ -25.88M	$ -19.39M	$ -10.09M
Normalized Income	$ -5.44M	$ -15.83M	-	$ -14.07M	$ -10.23M	$ -10.09M
Interest Expense	-	-	-	-	-	-
EBIT	$ -11.01M	$ -25.74M	$ -20.32M	$ -12.48M	$ -13.77M	$ -7.86M
EBITDA	$ -11.75M	$ -24.42M	$ -18.73M	$ -11.46M	$ -13.07M	$ -7.71M

Currency in USD

Predictive Oncology Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing